14-day Premium Trial Subscription Try For FreeGet Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.207 11 days ( -81.88 % )
Last Price $29.21 -0.545 %
High/ Low $29.20 - $29.39 1.52%
Chg 7 Days -0.375 % $29.32 $29.21
Chg 30 Days 85.58 % $15.74 $29.21
Chg 12 mos 462.81 % $5.19 $29.21
Trend - 3 mos 39.39 % Width: 77.08 %
Trend - 12 mos 161.78 % Width: 98.11 %
Pred. range - 3 mos $23.22 - $41.12 -20.50 % - 40.78 %
Pred. range - 12 mos $38.91 - $77.08 33.19 % - 163.87 %
Short mv avg 3 mos Sell 2023-12-07 - 2 days
Long mv avg 3 mos Buy 2023-11-13 - 19 days
Short/Long mv avg 3 mos Buy 2023-11-02 - 26 days
Short mv avg 12 mos Sell 2023-11-17 - 15 days
Long mv avg 12 mos Buy 2023-11-21 - 13 days
Short/Long mv avg 12 mos Buy 2023-11-29 - 8 days
Pivot Short Sell 2023-12-07 - 2 days
Bollinger Buy 2023-11-30 - 7 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT